Skip to Content
Merck
CN

A8530

m-Aminophenylboronic acid–Agarose

saline suspension

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12161501
PubChem Substance ID:
NACRES:
NA.32
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

saline suspension

Quality Level

extent of labeling

5-20 μmol per mL

matrix

cross-linked 6% beaded agarose

matrix activation

epoxy

matrix attachment

amino

matrix spacer

12 atoms

storage temp.

2-8°C

SMILES string

[X]Nc1cc(ccc1)B(O)O

General description

m-Aminophenylboronic acid–Agarose is applicable as a boronate affinity matrix for the purification of severe acute respiratory syndrome′s (SARS-CoV) nucleoprotein (NP) antigen.

Application

m-Aminophenylboronic acid–Agarose has been used as a separating gel in the boronate affinity chromatography of albumins. It has also been used as a resin for purification of 3,4-dihydroxyphenylacetaldehyde (DOPAL)-bound α-synuclein (α-syn).

Physical form

Suspension in 0.5 M NaCl, 0.1 M sodium acetate, pH 5.0.


Still not finding the right product?


Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content

Glycobiology and Glycoproteomics Brochure


N Plotegher et al.
Scientific reports, 7, 40699-40699 (2017-01-14)
Parkinson's disease is a neurodegenerative disorder characterized by the death of dopaminergic neurons and by accumulation of alpha-synuclein (aS) aggregates in the surviving neurons. The dopamine catabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) is a highly reactive and toxic molecule that leads to aS
Francesco Longo et al.
Acta neuropathologica communications, 5(1), 22-22 (2017-03-16)
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of Parkinson's disease. Here, we investigated whether the G2019S LRRK2 mutation causes morphological and/or functional changes at nigro-striatal dopamine neurons. Density of striatal dopaminergic terminals
null



Global Trade Item Number

SKUGTIN
A8530-5ML04061838160928